search
Back to results

Effects of Narrative Writing Duration and Post-writing Processing Instructions on PTSD

Primary Purpose

Posttraumatic Stress Disorder (PTSD)

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Narrative Writing: Trauma-Assigned
Narrative Writing: Trauma-Spontaneous
Sponsored by
University of Mississippi, Oxford
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Posttraumatic Stress Disorder (PTSD) focused on measuring Posttraumatic Stress Disorder (PTSD), Narrative Writing

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Experienced a traumatic life event (DSM-IV-TR Criterion A)
  • Currently experiencing clinically significant levels of PTSD symptoms

Exclusion Criteria:

  • Currently receiving psychotherapy
  • On medication that is not stable (i.e. medication has been changed within the past 6 weeks)

Sites / Locations

  • The University of Mississippi

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

No Intervention

Experimental

Active Comparator

Arm Label

Control

Narrative Writing: Trauma-Assigned

Narrative Writing: Trauma-Spontaneous

Arm Description

Individuals will write objectively about the events of their day.

Trauma-assigned: Individuals will write about their most traumatic life experience and be instructed to continue to think about their writing topic in the weeks following writing.

Individuals will write about their most traumatic life experience but will not be given further instructions for processing. Any additional processing about their writing topic in the weeks following writing will be considered spontaneous.

Outcomes

Primary Outcome Measures

Level of PTSD symptoms as measured by the Clinician Administered PTSD Scale

Secondary Outcome Measures

Physical health
Physical health as measured by the Pennebaker Inventory of Limibic Languidness (PILL)

Full Information

First Posted
January 18, 2013
Last Updated
May 14, 2014
Sponsor
University of Mississippi, Oxford
search

1. Study Identification

Unique Protocol Identification Number
NCT01773811
Brief Title
Effects of Narrative Writing Duration and Post-writing Processing Instructions on PTSD
Official Title
Effects of Narrative Writing Duration and Post-writing Processing Instructions on PTSD
Study Type
Interventional

2. Study Status

Record Verification Date
May 2014
Overall Recruitment Status
Completed
Study Start Date
February 2012 (undefined)
Primary Completion Date
May 2014 (Actual)
Study Completion Date
May 2014 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Mississippi, Oxford

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The current study proposes to directly measure how processing after participating in written disclosure about a traumatic life event affects physical and psychological outcomes.
Detailed Description
Previous research has established the potential for narrative writing about traumatic events to result in positive benefits for physical and psychological health. Research has also provided evidence that written disclosure may reduce post-traumatic stress disorder (PTSD) symptoms. Several mechanisms of action have been proposed to explain why written disclosure produces positive benefits, but all have focused on processes occurring during the writing session. It has been suggested, however, that additional processing may occur after the writing exercises are over, yet no research has studied the influence of this processing on outcomes. The current study proposes to directly measure how processing after participating in written disclosure affects physical and psychological outcomes.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Posttraumatic Stress Disorder (PTSD)
Keywords
Posttraumatic Stress Disorder (PTSD), Narrative Writing

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
49 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Control
Arm Type
No Intervention
Arm Description
Individuals will write objectively about the events of their day.
Arm Title
Narrative Writing: Trauma-Assigned
Arm Type
Experimental
Arm Description
Trauma-assigned: Individuals will write about their most traumatic life experience and be instructed to continue to think about their writing topic in the weeks following writing.
Arm Title
Narrative Writing: Trauma-Spontaneous
Arm Type
Active Comparator
Arm Description
Individuals will write about their most traumatic life experience but will not be given further instructions for processing. Any additional processing about their writing topic in the weeks following writing will be considered spontaneous.
Intervention Type
Behavioral
Intervention Name(s)
Narrative Writing: Trauma-Assigned
Intervention Description
Individuals will be writing about their most traumatic life event for 3 consecutive days for 20 minutes each. Those in the assigned group will be given instructions and weekly reminders to continue to think about their most traumatic event.
Intervention Type
Behavioral
Intervention Name(s)
Narrative Writing: Trauma-Spontaneous
Intervention Description
Individuals will be writing about their most traumatic life event for 3 consecutive days for 20 minutes each. Those in the spontaneous group will be given no further instructions.
Primary Outcome Measure Information:
Title
Level of PTSD symptoms as measured by the Clinician Administered PTSD Scale
Time Frame
1 month after final writing session
Secondary Outcome Measure Information:
Title
Physical health
Description
Physical health as measured by the Pennebaker Inventory of Limibic Languidness (PILL)
Time Frame
1 month after final writing session

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Experienced a traumatic life event (DSM-IV-TR Criterion A) Currently experiencing clinically significant levels of PTSD symptoms Exclusion Criteria: Currently receiving psychotherapy On medication that is not stable (i.e. medication has been changed within the past 6 weeks)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Tom Lombardo, PhD
Organizational Affiliation
University of Mississippi, Oxford
Official's Role
Principal Investigator
Facility Information:
Facility Name
The University of Mississippi
City
University
State/Province
Mississippi
ZIP/Postal Code
38677
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Effects of Narrative Writing Duration and Post-writing Processing Instructions on PTSD

We'll reach out to this number within 24 hrs